Abstract |
An anti- influenza compound, DP2392-E10 based on inhibition of the nuclear export function of the viral nucleoprotein- nuclear export signal 3 (NP-NES3) domain was successfully identified by our previous high-throughput screening system. Here, we demonstrated that DP2392-E10 exerts its antiviral effect by inhibiting replication of a broad range of influenza A subtypes. In regard to the molecular mechanism, we revealed that DP2392-E10 inhibits nuclear export of both viral NP and nuclear export protein (NEP). More specifically, in vitro pull-down assays revealed that DP2392-E10 directly binds cellular CRM1, which mediates nuclear export of NP and NEP. In silico docking suggested that DP2392-E10 binds at a region close to the HEAT9 and HEAT10 domains of CRM1. Together, these results indicate that the CRM1-mediated nuclear export function of influenza virus represents a new potential target for antiviral drug development, and also provide a core structure for a novel class of inhibitors that target this function.
|
Authors | Nopporn Chutiwitoonchai, Takafumi Mano, Michinori Kakisaka, Hirotaka Sato, Yasumitsu Kondoh, Hiroyuki Osada, Osamu Kotani, Masaru Yokoyama, Hironori Sato, Yoko Aida |
Journal | Virology
(Virology)
Vol. 507
Pg. 32-39
(07 2017)
ISSN: 1096-0341 [Electronic] United States |
PMID | 28399435
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2017 Elsevier Inc. All rights reserved. |
Chemical References |
- Antiviral Agents
- Karyopherins
- Nucleoproteins
- Receptors, Cytoplasmic and Nuclear
- exportin 1 protein
|
Topics |
- Active Transport, Cell Nucleus
(drug effects)
- Antiviral Agents
(pharmacology)
- Cell Line
- Cell Nucleus
(metabolism, virology)
- Humans
- Influenza A virus
(genetics, metabolism)
- Influenza, Human
(metabolism, virology)
- Karyopherins
(antagonists & inhibitors, genetics, metabolism)
- Nucleoproteins
(genetics, metabolism)
- Receptors, Cytoplasmic and Nuclear
(antagonists & inhibitors, genetics, metabolism)
|